Redi Breaks the In Between
The most important step in healthcare is the one no one owns. What happens after the decision is made and before the care actually happens.
What happens after the decision is made and before the care actually happens. On paper the process looks complete:
In reality, between a prescription being written and therapy truly beginning lies an invisible stretch of time where outcomes are determined.
The Fragile “In Between”
This is where prescriptions go unfilled, paperwork delays treatment, no-shows occur, and limited visibility and high therapy abandonment happens.
Healthcare is designed for clinical decision making, not for activation. The “in between” doesn’t fit neatly into a department, a workflow, or a reimbursement model. It isn’t funded or clearly owned, so it defaults to the patient.
Healthcare is designed for clinical decision-making, not for activation. The “in-between” doesn’t fit neatly into a department, a workflow, or a reimbursement model. It isn’t funded or clearly owned, so it defaults to the patient.
But patients aren’t system navigators. They’re people balancing work, family, uncertainty, and fear.
And when the in between breaks, care doesn’t happen. Outcomes decline.
The Gap Is the System
At Redi, we believe the decision is not care, care is what actually happens next. Alongside our Pharma partners, we’re co-building the connective layer that guides patients from decision to action — closing the most expensive and most overlooked gap in healthcare.
Engineering the Path from Prescription to Outcome
The future of healthcare won’t be defined solely by better clinical decisions. It will be defined by better follow-through.
Across therapeutic areas, first-fill abandonment and early discontinuation remain among the most persistent drivers of avoidable cost and poor outcomes. Scripts go unfilled, therapy is abandoned after the first month, side effects go unreported, and refills lapse. Clinical efficacy assumes adherence, and the real world rarely delivers it.
At Redi, we are building the connective layer between decision and action. This is where adherence is won or lost, where trust is built, cost curves bend, and outcomes are determined. Healthcare needs more decisions that turn to care. And that starts with owning the in between.
How Does Redi Own the In Between?
Pharmaceutical manufacturers, caregivers, and patients need a unified platform that consolidates all of those functionalities into a single experience — network:
- Enrollment tools simplify access for individuals on therapy and integrate with stakeholders across the healthcare ecosystem, including independent and specialty pharmacies.
- Whole Health Engagement tools provide patients with practical support — from nutrition and activity guidance to medication reminders — across all their prescriptions, no matter the manufacturer.
- Case Management software equips pharmaceutical companies with real-time connectivity and integrated data to keep healthcare providers and field teams updated with the status of patient journeys among multiple stakeholders.
- Patient Support includes integrating and branding patient experiences, delivering financial assistance, medications, call scheduling, and nurse support to sustain patients over the long term.
Redi empowers pharmaceutical companies to translate PSP investments into measurable health outcomes and long-term brand equity. By delivering personalized, timely support at critical points in the patient journey, Redi helps ensure therapies reach the right patients and sustain engagement and adherence over time.